Skip to main content

Mass Balance Recovery

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

InventisBio
InventisBioChina - Shanghai
1 program
1
[14C]-D-0502Phase 11 trial
Active Trials
NCT05339633Completed8Est. Oct 2022

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
InventisBio[14C]-D-0502

Clinical Trials (1)

Total enrollment: 8 patients across 1 trials

Study in Healthy Adult Female Subjects

Start: Mar 2022Est. completion: Oct 20228 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.